Main menu

Shining a light on the FCGR locus; genomic analysis of germline and somatic lesions


Monoclonal antibody (mAb) immunotherapy is becoming standard in the treatment of cancer, particularly for B-cell lymphoma patients, however responses are variable and relapse is common. Thus, the molecular mechanisms that underpin resistance needs to be defined.

Download the PDF

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

About Oxford Nanopore

Contact us News Media resources & contacts Investor centre Careers BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
English flag